Treatment Options From 5 Experts for Patients With Ovarian Cancer

Did you recently receive a diagnosis of ovarian cancer? CCO has developed an Interactive Decision Support Tool to help you understand more about your disease and treatment options. Answer these multiple choice questions about your diagnosis and see treatment plans from 5 ovarian cancer experts.

Share

Program Content

Activities

Ovarian Checklist
Patient-Focused Interactive Treatment Tool: Key Information You Need to Know About Your Advanced Ovarian Cancer Diagnosis
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2020

Expires: May 20, 2021

Activities

Ovarian Cancer Patient Tool
Treatment Options From 5 Experts for Advanced Ovarian Cancer: An Online Tool for Patients
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2020

Expires: May 20, 2021

Faculty

cover img faculity

Robert E. Coleman, MD, FRCP

Professor and Honorary Consultant Medical Oncologist
Cancer Clinical Trials Centre
Academic Unit of Clinical Oncology
Weston Park Hospital
Sheffield, England

cover img faculity

Thomas J. Herzog, MD

Associate Professor
Division of Gynecology
Washington University
St Louis, Missouri

cover img faculity

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Faculty Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Bradley Monk, MD

Professor, Division of Gynecologic Oncology
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine
Creighton University School of Medicine at St. Joseph's Hospital Medical
Medical Director, US Oncology Research Network — Gynecologic Program
Co-Director, GOG-Partners
Member, Board of Directors, GOG-Foundation
Phoenix, Arizona

cover img faculity

Kathleen N. Moore, MD, MS, FASCO

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Provided by

ProCE Banner

Supporters

Supported by independent educational grants from

Clovis Oncology

Tesaro